Comparative Study of the Effects of Fluconazole and Voriconazole on Candida glabrata, Candida parapsilosis and Candida rugosa Biofilms
- 344 Downloads
Infections by non-albicans Candida species are a life-threatening condition, and formation of biofilms can lead to treatment failure in a clinical setting. This study was aimed to demonstrate the in vitro antibiofilm activity of fluconazole (FLU) and voriconazole (VOR) against C. glabrata, C. parapsilosis and C. rugosa with diverse antifungal susceptibilities to FLU and VOR. The antibiofilm activities of FLU and VOR in the form of suspension as well as pre-coatings were assessed by XTT [2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide] reduction assay. Morphological and intracellular changes exerted by the antifungal drugs on Candida cells were examined by scanning electron microscope (SEM) and transmission electron microscope (TEM). The results of the antibiofilm activities showed that FLU drug suspension was capable of killing C. parapsilosis and C. rugosa at minimum inhibitory concentrations (MICs) of 4× MIC FLU and 256× MIC FLU, respectively. While VOR MICs ranging from 2× to 32× were capable of killing the biofilms of all Candida spp tested. The antibiofilm activities of pre-coated FLU were able to kill the biofilms at ¼× MIC FLU and ½× MIC FLU for C. parapsilosis and C. rugosa strains, respectively. While pre-coated VOR was able to kill the biofilms, all three Candida sp at ½× MIC VOR. SEM and TEM examinations showed that FLU and VOR treatments exerted significant impact on Candida cell with various degrees of morphological changes. In conclusion, a fourfold reduction in MIC50 of FLU and VOR towards ATCC strains of C. glabrata, C. rugosa and C. rugosa clinical strain was observed in this study.
KeywordsBiofilms Non-albicans Candida Fluconazole Voriconazole XTT assay Electron microscopy
The authors are grateful to the staff of the Microscopy Unit, Institute of Biosciences, Universiti Putra Malaysia, for their expert technical assistance. We are also thankful to Glenmark Generics Limited, India, for the kind gift of voriconazole powder used in this study.
This work was supported by Universiti Putra Malaysia (UPM) through the Research University Grant Scheme (RUGS No. 9333100) funded by the Ministry of Higher Education (MOHE), Putrajaya, Malaysia.
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Tortora GJ, Funke BR, Case CL. Principles of diseases and epidemiology. In: Microbiology: an introduction. 11th ed. Benjamin Cummings: Pearson; 2012. p. 422–3.Google Scholar
- 11.Canton E, Peman J, Quindos G, Eraso E, Miranda-Zapico I, Alvarez M, Merino P, Campos-Herrero I, Marco F, de la Pedrosa EG, Yague G, Guna R, Rubio C, Miranda C, Pazos C, Valssco D, FUNGEMYCA Study Group. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia. Antimicrob Agents Chemother. 2011;55(12):5590–6.CrossRefPubMedPubMedCentralGoogle Scholar
- 12.da Silva BV, Silva LB, de Oliveira DB, da Silva PR, Ferreira-Paim K, Andrade-Silva LE, Silva-Vergara ML, Andrade AA. Species distribution, virulence factors, and antifungal susceptibility among Candida parapsilosis complex isolates recovered from clinical specimens. Mycopathologia. 2015;180(5–6):333–43.CrossRefPubMedGoogle Scholar
- 13.Ziccardi M, Souza LO, Gandra RM, Galdino AC, Baptista AR, Nunes AP, Ribeiro MA, Branquinha MH, Santos AL. Candida parapsilosis (sensu lato) isolated from hospitals located in the Southeast of Brazil: species distribution, antifungal susceptibility and virulence attributes. Int J Med Microbiol. 2015;305(8):848–59.CrossRefPubMedGoogle Scholar
- 22.Raad II, Hachem RY, Hanna HA, Fang X, Jiang Y, Dvorak T, Sheretz RJ, Kontoyiannis DP. Role of ethylene diamine tetra-acetic acid (EDTA) in catheter lock solutions: EDTA enhances the antifungal activity of amphotericin B lipid complex against Candida embedded in biofilm. Int J Antimicrob Agents. 2008;32(6):515–8.CrossRefPubMedGoogle Scholar
- 24.Scorzoni L, de Lucas MP, Mesa-Arango AC, Fusco-Almeida AM, Lozano E, Cuenca-Estrella M, Mendes-Giannini MJ, Zaragoza O. Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile. PLoS ONE. 2013;8(3):e60047.CrossRefPubMedPubMedCentralGoogle Scholar
- 27.CLSI. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. In: Proceedings of the 22nd informational supplement M100-S22, CLSI, Wayne, PA, USA. 2012; 32(2).Google Scholar
- 28.Pierce CG, Uppuluri P, Tristan AR, Wormley FL Jr, Mowat E, Ramage G, Lopez-Ribot JL. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc. 2008;3(9):1494–500.CrossRefPubMedPubMedCentralGoogle Scholar
- 29.Pierce CG, Chaturvedi AK, Lazzell AL, Powell AT, Saville SP, McHardy SF, Lopez-Ribot JL. A novel small molecule inhibitor of Candida albicans Biofilm formation, filamentation and virulence with low potential for the development of resistance. NPJ Biofilms Microbiomes. 2015;1:15012.CrossRefPubMedPubMedCentralGoogle Scholar
- 32.Shin JH, Kee SJ, Shin MG, Kim SH, Shin DH, Lee SK, Suh SP, Ryang DW. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol. 2002;40(4):1244–8.CrossRefPubMedPubMedCentralGoogle Scholar
- 41.Butler G, Sullivan DJ. Comparative genomics of Candida species. In: Enfert and Hube’s Candida: comparative and functional genomics. U.K.: Caister Academic Press; 2007.Google Scholar
- 42.Seker E, Ozenc E. In vitro biofilm activity of Candida species isolated from Anatolian buffaloes with mastitis in Western Turkey. Veterinarski Arhiv. 2011;N81(6):723–30.Google Scholar
- 58.Kumar D, Banerjee T, Chakravarty J, Singh SK, Dwivedi A, Tilak R. Identification, antifungal resistance profile, in vitro biofilm formation and ultrastructural characteristics of Candida species isolated from diabetic foot patients in Northern India. Indian J Med Microbiol. 2016;34(3):308–14.CrossRefPubMedGoogle Scholar